Charles River Laboratories International Inc
F:RV6
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
C
|
Charles River Laboratories International Inc
F:RV6
|
US |
|
F
|
Fresenius Medical Care AG
DUS:FME
|
DE |
|
A
|
AT & S Austria Technologie & Systemtechnik AG
XHAM:AUS
|
AT |
|
M
|
MacroAsia Corp
XPHS:MAC
|
PH |
|
R
|
Regency Centers Corp
F:RRC
|
US |
|
F
|
Ford Motor Co
XHAM:FMC1
|
US |
|
I
|
Intershop Holding AG
SWB:ISZN
|
CH |
|
V
|
Veolia Environnement SA
XMUN:VVD
|
FR |
|
Ion Energy Ltd
XTSX:ION
|
CA |
Wall St Price Targets
RV6 Price Targets Summary
Charles River Laboratories International Inc
According to Wall Street analysts, the average 1-year price target for RV6 is 165.31 EUR with a low forecast of 102.21 EUR and a high forecast of 196 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is RV6's stock price target?
Price Target
165.31
EUR
According to Wall Street analysts, the average 1-year price target for RV6 is 165.31 EUR with a low forecast of 102.21 EUR and a high forecast of 196 EUR.
What is the Revenue forecast for Charles River Laboratories International Inc?
Projected CAGR
4%
Over the last 13 years, the compound annual growth rate for Revenue has been 10%. The projected CAGR for the next 8 years is 4%.
What is the Gross Profit forecast for Charles River Laboratories International Inc?
Projected CAGR
4%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 10%. The projected CAGR for the next 8 years is 4%.
What is the Operating Income forecast for Charles River Laboratories International Inc?
Projected CAGR
15%
Over the last 13 years, the compound annual growth rate for Operating Income has been 9%. The projected CAGR for the next 5 years is 15%.
